Showing results (21-30 of 52) with videos related to
Sort By:
Pageof 6
Diagnostics (Basel, Switzerland)|December 11, 2025
Bronchial Physiological Saline Injection to Visualize Peripheral Pulmonary Lesions in Ultrathin BronchoscopyMika Nakao, Tamio Okimoto, Noriaki Kurimoto, et al.Thoracic Cancer|August 29, 2025
Pure Red Cell Aplasia That Developed 13 Years After Thymoma Treatment: A Case Report and Literature ReviewKento Kono, Kazuhisa Nakashima, Yukari Tsubata, et al.Anticancer Research|May 6, 2021
ERCC1 Is a Predictive Biomarker for Non-small Cell Lung Cancer But Is Antibody-dependentTamio Okimoto, Yukari Tsubata, Ryosuke Tanino, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2020
Circulating MicroRNAs and Extracellular Vesicle-Containing MicroRNAs as Response Biomarkers of Anti-programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLCTakehito Shukuya, Vikas Ghai, Joseph M Amann, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2019
The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung CancerTakehito Shukuya, Tadaaki Yamada, Michael J Koenig, et al.Respiratory Investigation|February 28, 2020
Comparison of the chest computed tomography findings between patients with pulmonary tuberculosis and those with Mycobacterium avium complex lung diseaseKiyotaka Miura, Megumi Nakamura, Yasuyuki Taooka, et al.Internal Medicine (Tokyo, Japan)|March 18, 2014
Solitary fibrous tumor with rapid progression after 16 years' follow upTamio Okimoto, Yasushi Horimasu, Shunichi Hamaguchi, et al.Thoracic Cancer|March 20, 2023
Immune-related adverse events in hepatitis treated with thiopurine-based immunosuppressants: A case reportKeita Kawakado, Kazuhisa Nakashima, Hiroshi Tobita, et al.Frontiers in Health Services|July 10, 2026
Time course of postmortem procedures in a palliative care unitTamio Okimoto, Shintaro Shimizu, Ken Yoshihara, et al.Respirology Case Reports|April 13, 2023
An 83-year-old patient with RET fusion-positive non-small cell lung cancer experiencing severe hepatic disorder due to selpercatinib administrationKazuhisa Nakashima, Yuki Mitarai, Seiko Tanaka, et al.Pageof 6